- Report
- July 2025
- 480 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- June 2025
- 200 Pages
Global
From €2527EUR$2,789USD£2,178GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2527EUR$2,789USD£2,178GBP
- Report
- June 2025
- 150 Pages
Global
From €2445EUR$2,699USD£2,107GBP
- Report
- August 2024
- 178 Pages
Global
From €2265EUR$2,500USD£1,952GBP
- Report
- September 2024
- 29 Pages
United States
From €995EUR$1,177USD£888GBP
- Report
- February 2023
- 317 Pages
Global
From €4529EUR$5,000USD£3,904GBP
- Report
- May 2024
- 138 Pages
Global
From €5887EUR$6,499USD£5,075GBP
- Report
- May 2024
- 182 Pages
Global
From €3465EUR$3,825USD£2,987GBP
€4077EUR$4,500USD£3,514GBP
- Report
- November 2023
- 182 Pages
Global
From €3465EUR$3,825USD£2,987GBP
€4077EUR$4,500USD£3,514GBP
- Report
- April 2023
- 115 Pages
Global
From €4303EUR$4,750USD£3,709GBP
- Report
- January 2022
- 111 Pages
Global
From €4303EUR$4,750USD£3,709GBP
- Report
- April 2024
- 140 Pages
Global
From €4483EUR$4,949USD£3,864GBP
- Report
- May 2023
- 160 Pages
Global
From €4483EUR$4,949USD£3,864GBP
- Report
- February 2022
- 39 Pages
Global
From €1812EUR$2,000USD£1,562GBP
- Report
- January 2025
- 25 Pages
India
From €995EUR$1,177USD£888GBP
- Report
- October 2024
- 26 Pages
Taiwan
From €995EUR$1,177USD£888GBP
- Report
- October 2024
- 22 Pages
Uzbekistan
From €995EUR$1,177USD£888GBP
- Report
- September 2024
- 29 Pages
South Korea
From €995EUR$1,177USD£888GBP
- Report
- September 2024
- 26 Pages
Australia
From €995EUR$1,177USD£888GBP

The Decongestant market is a subset of the Cough and Cold Drugs market, which includes medications used to treat symptoms of the common cold, such as nasal congestion, sinus pressure, and chest congestion. Decongestants are typically available in both over-the-counter (OTC) and prescription forms, and are often used in combination with other medications to treat cold and flu symptoms. Decongestants work by narrowing the blood vessels in the nasal passages, reducing inflammation and allowing for easier breathing.
Common OTC decongestants include pseudoephedrine, phenylephrine, and oxymetazoline. Prescription decongestants include ephedrine, phenylephrine, and phenylpropanolamine. Decongestants are also available in combination with other medications, such as antihistamines, expectorants, and cough suppressants.
Some companies in the Decongestant market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more